Design Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 02/13/2025 | 6.53 M | $40.27 M | 0.00% | 11.53% |
MACKENZIE FINANCIAL CORP | 02/20/2025 | 4.95 M | $561.83 M | 130.42% | 8.74% |
LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 4.22 M | $26.02 M | 0.00% | 7.45% |
CONESTOGA CAPITAL ADVISORS, LLC | 01/24/2025 | 3.15 M | $357.90 M | -0.57% | 5.56% |
DURABLE CAPITAL PARTNERS LP | 02/14/2025 | 2.92 M | $331.21 M | -15.63% | 5.15% |
JARISLOWSKY, FRASER LTD | 02/14/2025 | 2.71 M | $306.21 M | -4.68% | 4.78% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.58 M | $15.92 M | 9.36% | 4.56% |
FIERA CAPITAL CORP | 01/29/2025 | 2.54 M | $288.75 M | -1.39% | 4.49% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.95 M | $12.05 M | 3.22% | 3.45% |
PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 1.92 M | $217.83 M | -9.31% | 3.39% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 1.90 M | $215.85 M | -0.58% | 3.36% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.86 M | $11.46 M | 15.99% | 3.28% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 1.77 M | $200.72 M | 6.08% | 3.12% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 1.74 M | $10.76 M | 0.00% | 3.08% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.69 M | $192.50 M | 23.88% | 2.99% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.48 M | $9.14 M | 0.00% | 2.62% |
GENEVA CAPITAL MANAGEMENT LLC | 02/06/2025 | 1.46 M | $165.76 M | -1.19% | 2.58% |
ALMITAS CAPITAL LLC | 02/14/2025 | 1.32 M | $8.17 M | 0.00% | 2.34% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/12/2025 | 1.20 M | $136.18 M | 114.35% | 2.12% |
CONGRESS ASSET MANAGEMENT CO /MA | 01/30/2025 | 1.18 M | $134.12 M | -2.58% | 2.09% |
NORGES BANK | 02/12/2025 | 1.12 M | $126.92 M | 100.00% | 1.97% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 899,762 | $102.22 M | 3.24% | 1.59% |
RIVERBRIDGE PARTNERS LLC | 01/17/2025 | 800,923 | $90.98 M | -7.54% | 1.41% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 776,082 | $4.79 M | 100.00% | 1.37% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 769,753 | $87.44 M | 9.08% | 1.36% |
NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 730,778 | $83.15 M | 4.52% | 1.29% |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/29/2025 | 665,134 | $75.50 M | 18.16% | 1.17% |
LORD, ABBETT & CO. LLC | 02/14/2025 | 657,712 | $74.72 M | -2.26% | 1.16% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 635,722 | $72.23 M | 0.56% | 1.12% |
GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 601,962 | $68.38 M | -1.95% | 1.06% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2025 | 595,448 | $67.64 M | 1.76% | 1.05% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 567,604 | $3.50 M | -2.67% | 1.00% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 565,671 | $64.39 M | -3.28% | 1.00% |
BIOIMPACT CAPITAL LLC | 02/14/2025 | 559,547 | $3.45 M | 100.00% | 0.99% |
D. E. SHAW & CO., INC. | 02/14/2025 | 512,330 | $3.16 M | -12.10% | 0.90% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 02/12/2025 | 501,486 | $56.97 M | 6.56% | 0.89% |
PRAESIDIUM INVESTMENT MANAGEMENT COMPANY, LLC | 02/14/2025 | 481,725 | $54.72 M | 100.00% | 0.85% |
BANK OF NOVA SCOTIA | 02/13/2025 | 459,576 | $52.23 M | 1.19% | 0.81% |
SEGALL BRYANT & HAMILL, LLC | 02/11/2025 | 447,808 | $50.87 M | 2.11% | 0.79% |
BAIRD FINANCIAL GROUP, INC. | 02/14/2025 | 430,369 | $48.89 M | -8.78% | 0.76% |
VONTOBEL HOLDING LTD. | 01/30/2025 | 430,016 | $48.82 M | 104.50% | 0.76% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 426,683 | $2.63 M | 692.59% | 0.75% |
PREMIER FUND MANAGERS LTD | 02/12/2025 | 411,419 | $46.95 M | 0.00% | 0.73% |
NEUBERGER BERMAN GROUP LLC | 02/13/2025 | 396,740 | $45.07 M | -0.58% | 0.70% |
CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 352,421 | $40.04 M | -16.89% | 0.62% |
MORGAN STANLEY | 02/14/2025 | 346,183 | $2.14 M | -19.27% | 0.61% |
BLAIR WILLIAM & CO/IL | 02/12/2025 | 325,958 | $37.03 M | 3.68% | 0.58% |
DF DENT & CO INC | 02/12/2025 | 270,557 | $30.74 M | -3.26% | 0.48% |
MORGAN STANLEY | 02/14/2025 | 269,596 | $30.63 M | -24.52% | 0.48% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 257,935 | $29.28 M | -28.77% | 0.46% |
Design Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 405 institutional investors and hedge funds held shares of Design Therapeutics, Inc.. The most heavily invested institutionals were:
SR ONE CAPITAL MANAGEMENT, LP: 6.53 M
MACKENZIE FINANCIAL CORP: 4.95 M
Logos Global Management LP: 4.22 M
BlackRock Funding, Inc. /DE: 3.35 M
Conestoga Capital Advisors, LLC: 3.15 M
Durable Capital Partners LP: 2.92 M
156.59% of Design Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 80.76 M shares in the last 24 months. This purchase volume represents approximately $398.12 M in transactions.